EssaysForStudent.com - Free Essays, Term Papers & Book Notes
Search

Corporate Financial Analysis: A Case on Square Pharmaceuticals Ltd.

Page 1 of 6

PROSPECT ANALYSIS

Making a projection of the future is very challenging due to the uncertain future. The stock prices are very much interest sensitive as well as very quickly absorbing to any news in the market.

In brief, the prospect analysis of Square Pharma is based on the current and past data from 2011 to 2015.

A snap shot of the financial statements is given below:

BALANCE SHEET

2010-2011

2011-2012

2012-2013

2013-2014

2014-2015

(Year)

(Year)

(Year)

(Year)

(Year)

Balance Sheet

Non Current Assets

16,313,597,638

16,313,597,638

20,605,309,448

23,546,701,250

25,458,986,164.00

Current Assets:

8,248,571,022

8,248,571,022

6,946,361,767

7,499,373,281

9,732,170,099.00

Total Assets

24,562,168,660

24,562,168,660

27,551,671,215

31,046,074,531

35,191,156,263.00

Shareholders' Equity

19,258,829,020

19,258,829,020

22,593,944,897

26,748,951,732

31,091,632,420.00

Non Current Liabilities

987,949,283

987,949,283

1,682,318,885

1,902,585,673

1,550,505,777.00

Current Liabilities

4,315,390,357

4,315,390,357

3,275,407,433

2,394,537,126

2,549,018,066.00

Book Value Per Share

72.72

72.72

60.94

55.5

56.09

Total Liabilities & Shareholders Equity

24,562,168,660

24,562,168,660

27,551,671,215

31,046,074,531

35,191,156,263.00

INCOME STATEMENT

2010-2011

2011-2012

2012-2013

2013-2014

2014-2015

(Year)

(Year)

(Year)

(Year)

(Year)

Income statement

Turnover

16,054,425,243

19,798,082,092

20,202,005,922

23,268,413,217

26,684,573,116.00

Cost of goods sold

9,167,253,620

11,907,772,974

11,308,857,708

12,960,738,683

14,942,870,155.00

Gross profit

6,887,171,623

7,890,309,118

8,893,148,214

10,307,674,534

11,741,702,961.00

Profit from operations

3,754,727,749

4,615,536,767

5,198,704,396

6,144,784,666

7,208,225,885.00

Net profit before tax

3,978,939,088

4,350,072,181

4,972,669,597

5,912,348,302

6,963,547,022.00

Net profit after tax

2,897,710,641

3,125,019,992

3,637,997,573

4,250,580,863

5,186,436,869.00

Earnings Per Share

10.94

9.76

8.74

10.26

10.8

Download as (for upgraded members)  txt (12.6 Kb)   pdf (289.6 Kb)   docx (34.2 Kb)  
Continue for 5 more pages »